期刊文献+

Does Fasciola hepatica infection modify the response of acute hepatitis C virus infection to IFN-α treatment?

Does Fasciola hepatica infection modify the response of acute hepatitis C virus infection to IFN-α treatment?
下载PDF
导出
摘要 Immunologic response to acute hepatitis C is mainly a Th1 response, whereas fasciolopsiasis is associated with a diverse T-cell response. Interferon-alpha has immunomodulatory effects and enhances Th1 immune response. Fasciola infection could theoretically interfere with the Th1 immune response, even when acquired after an initial response to interferon-alpha treatment for acute hepatitis C virus (HCV) infection. We report here the case of a male patient who acquired Fasciola hepatica infection after an initial response to IFN-alpha therapy with a favorable outcome. Immunologic response to acute hepatitis C is mainly a Th1 response, whereas fasciolopsiasis is associated with a diverse T-cell response. Interferon-alpha has immunomodulatory effects and enhances Th1 immune response. Fasciola infection could theoretically interfere with the Th1 immune response, even when acquired after an initial response to interferon-alpha treatment for acute hepatitis C virus (HCV) infection. We report here the case of a male patient who acquired Fasciola hepatica infection after an initial response to IFN-alpha therapy with a favorable
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第48期7688-7689,共2页 世界胃肠病学杂志(英文版)
关键词 Hepatitis C INTERFERON Fasciola hepatica 丙型肝炎病毒 IFN-α 治疗 地钱属 獐耳细辛
  • 相关文献

参考文献13

  • 1[1]Jacobson Brown PM,Neuman MG.Immunopathogenesis of hepatitis C viral infection:Th1/Th2 responses and the role of cytokines.Clin Biochem 2001; 34:167-171
  • 2[2]O'Neill SM,Brady MT,Callanan JJ,Mulcahy G,Joyce P,Mills KH,Dalton JP.Fasciola hepatica infection downregulates Th1 responses in mice.Parasite Immunol 2000; 22:147-155
  • 3[3]Carnevale S,Rodriguez MI,Santillan G,Labbe JH,Cabrera MG,Bellegarde EJ,Velasquez JN,Trgovcic JE,Guarnera EA.Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA.Clin Diagn Lab Immunol 2001; 8:174-177
  • 4[4]Foster GR.Interferons in host defense.Semin Liver Dis 1997;17:287-295
  • 5[5]Koziel MJ.The role of immune responses in the pathogenesis of hepatitis C virus infection.J Viral Hepat 1997; 4 Suppl 2:31-41
  • 6[6]Woitas RP,Lechmann M,Jung G,Kaiser R,Sauerbruch T,Spengler U.CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.J Immunol 1997; 159:1012-1018
  • 7[7]Lechmann M,Ihlenfeldt HG,Braunschweiger I,Giers G,Jung G,Matz B,Kaiser R,Sauerbruch T,Spengler U.T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.Hepatology 1996; 24:790-795
  • 8[8]Brady MT,O'Neill SM,Dalton JP,Mills KH.Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis.Infect Immun 1999; 67:5372-5378
  • 9[9]Kamal SM,Rasenack JW,Bianchi L,Al Tawil A,El Sayed Khalifa K,Peter T,Mansour H,Ezzat W,Koziel M.Acute hepatitis C without and with schistosomiasis:correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.Gastroenterology 2001; 121:646-656
  • 10[10]Dianzani F.Biological basis for the clinical use of interferon.Gut 1993; 34:74-76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部